Rheumatology Flashcards

1
Q

Sjogren’s syndrome

A

incidence: 4/100,000

definition: chronic AI inflammatory disorder with decreased lacrimal and salivary gland function

clinical:

  • dry eyes
  • dry mouth: caries, hyperlobulated tongue, loss of filiform papillae
  • parotid gland enlargement

diagnosis:

  • elevated ANA (SSA/SSB)
  • positive biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sulfasalazine

A

class: sulfa drug (sulfasalazine + sulfa AB)

mechanism: antiinflammatory not well understood

use: JIA, RA, IBD

SE: agranulocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hydroxychloroquinine

(Plaquenil)

A

mechanism: increase cell pH and interfere with Ag presentation

use: antimalarial, JIA

SE: GI, trigger G6PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Arthritis

A

inflammation of a joint with at least 2 of the following:

1. swelling: effusion or synovial thickening

2. joint line tenderness

3. pain at end of ROM

causes:

  • hepatitis, IBD, mediterranian fever, sarcoid, CF, T21, Turner’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Growing pains

A

definition: benign nocturnal limb pain

incidence: 10-20% aged 3 to 7 years

etiology: unknown

risk factors: boys>girls, active

clinical: deep crampy pains in calves/thigh in evening or waking from sleep

tx: NSAIDs, reassurance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SLE

A

incidence: 10/100,000, girls 8: boys 1, >5 years

etiology: unknown but large amounts of circulating autoantibodies

clinical:

  • skin (95%): malar rash, discoid lupus, photosensitivity, oral ulcers, lupus panniculitis
  • msk: arthralgia, non-deforming arthritis
  • CVS: pleuritis, pericarditis, CAD
  • neuro: seizures, psychosis
  • renal: nephritis 50-70% (20% ESKD at 10yrs)
  • GI: pancreatitis, colitis, SM
  • haem: anaemia, thrombocyaenia, low complement

investigations:

  • positive ANA (97%)
  • positive anti-dsDNA (specific)
  • anti-Sm (30% but specific)
  • anti SSA/SSB
  • antiphospholipid Abs (66%): anticardiolipin, Lupus anticoagulant
  • false positive VDRL

treatment: corticosteroids, hydroxychloroquinine, azathioprine, MTX

disease monitoring: dsDNA, complement, ESR

prognosis: 10yr survival 85%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Juvenille Idiopathic Arthritis

(JIA)

A

incidence: 1/1000 F>M, peaks 2yrs and 10 yrs

types:

1. oligoarthritis (50%): <5 joints (medium/large joint) in 6 mths

  • associated HLA-DR5 and HLA-DR8
  • associated uveitis 20% (80% if ANA positive)

2. polyarthritis (40%): >4 joints (symmetric/small joint) in 6 mths

  • associated HLA-DR4
  • RF +ve may suggest early onset RA

3. systemic onset JIA (10%): daily fevers with morbilliform rash +/- pleuritis/pericarditis (50%), HSM (70%) with arthritis at 6wks to 6mths

  • increased inflammatory markers
  • ANA/RF rarely positive

diagnosis: ANA (40-85%) and associated uveitis

treatment: NSAIDs, corticosteroids, DMARDs

prognosis:

  • 85% resolves by adulthood
  • poorer prognosis with polyarthritis/systemic-onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Periodic fever with apthous stomatitis, pharyngitis and adenitis

(PFAPA syndrome)

A

definition: autoinflammatory disorder without autoAb/T cells

etiology: unknown

clinical: ages 2-5 yrs

  • fever 3-6 days every 4 weeks
  • apthous ulcers 70%
  • pharyngitis
  • other: headache, myalgia, coryza

diagnosis:

  • clinical diagnosis after more than 3 episodes
  • elevation inflammatory cytokines

prognosis: self-limited for <8years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Juvenille Ankylosing Spondylitis

A

incidence: 1/1000 M>F

definition: inflammation of axial skeleton and sacroiliac joints and enthesitis

genetics: HLA-B27 (>95%)

clinical:

  • msk: low back pain/stiffness <3months worse in morning, sacroilitis, enthesis, peripheral arthritis
  • other: anterior uveitis, CVS disease renal (IgA nephropathy/amyloidosis)

diagnosis: HLA-B27 positive, ANA/RF negative

  • XR: SIJ changes
  • Schober test: >15cm increase spinal distance w/ flexion

treatment: early with TNF blockers, NSAIDs, DMARDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Psoriatic Arthritis

A

incidence: F>M

genetics: HLA-B27 (>95%)

clinical:

  • msk: arthritis <5 any joints, dactylitis
  • skin: psoriasis 40-60%, nail changes (50-80%), DIP
  • ocular: posterior uveitis (10-15%)

diagnosis: HLA-B27 positive, ANA positive (60%), RF -ve

treatment: early with TNF blockers, NSAIDs, DMARDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Reactive arthritis

A

definition: arthritis preceded by enteric or urinary infection

clinical: arthritis + urethritis + conjunctivitis

  • msk: oligoarthritis of LL joints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rheumatoid arthritis

A

definition: symmetric inflammatory peripheral polyarthritis of unknown etiology

etiology: destruction of bone due to reactive osteoclasts

diagnosis: RF 70-80%, Anti-CCP Abs (specific)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Familial Mediterranean Fever

A

definition: hereditary autoinflammatory disorder with sporadic recurrent fever and serosal inflammation

genetics: AR, MEFV gene

clinical: onset <10 years

  • reccurent fever
  • serositis: abdominal pain (95%), chest pain (45%), arthritis (75%)
  • erysipelas skin lesions (40%)
  • complication: pericarditis, orchitis

investigations: elevated serum markers

long term complications: secondary amyloidosis , SBO, infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TNF receptor 1 associated periodic syndrome

(TRAPS)

A

incidence: 1:1 million

genetics: AD TNFR1 gene

clinical: onset <10yrs

  • reccurent fevers 5-6 weeks
  • other: myagias, conjunctivitis, periorbital oedema, abdo pain, arthritis, rash

long term issues:

  • secondary amyloidosis (15%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mycophenolate

MMF

A

mechanism: immunosuppresant blocks enzyme required for purine synthesis and presents proliferation T/B cells

use: post transplant, rheum diseases

side effects:

  • GI most common (75%)
  • BM suppression (5%)
  • increased risk of infection/neoplasms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Juvenille Polymyositis

JPM

A

incidence: 3-6% childhood idiopathic inflammatory myopathies

pathophysiology: genetic T cell invasion muscle fibres

clinical: symmetrical proximal muscle weakness

diagnosis: ANA +ve 70%

17
Q

Cause of hip pain by age

A

2-6yrs: transient synovitis

4-10yrs: perthe’s disease

10-14yrs: slipped capital femoral epiphysis

18
Q

Rheumatoid factor

A

Rheumatoid arthritis 26-90%

Sjogren’s syndrome 75-95%

mixed connective tissue disease 50-60%

SLE 15-35%

polymyositis/dermatomyositis 5-10%

19
Q

Scleroderma

A

clinical (CREST):

Calcinosis, Raynaud’s, Esophageal, Sclerodactyly, Telangiectasia

  • skin: thickening and tethering
  • vascular: dysfunction, Raynaud’s, thromboembolism
  • GI: esophageal hypomobility, dysfunction
  • pulmonary: ILD, pulmonary vascular disease, lung cancer
  • renal: renal crisis
  • cardiac: pericarditis, pericardial effusion, fibrosis, mycocarditic
  • other: fatigue, myalgia, pain, sleep difficulties

diagnosis:

  • ANA + (95%), Scl-70, ACA (20-50%), anti-RNA polymerase II (20-50%)
20
Q

ANCA

A

associated vasculitides

Wegener’s granulomatosis 90%

Microscopic polyangitis 70%

Churg-Strauss syndrome 50%

Anti-GBM Ab disease 10-40%

21
Q

Granulomatosis with polyangiitis

(Wegener’s)

A

incidence: uncommon in children, caucasian

pathogenesis: SMALL vessel vasculitis

clinical:

  • systemic: fatigue, fever, weight loss, arthralgias
  • ENT: sinusitis, rhinorrhea, OM, SNHL
  • pulmonary: cough, dyspnoea, stridor, wheeze, haemoptysis
  • renal: glomerulonephritis (85%)
  • skin: purpura, ulcers, uveitis, retinal vasculitis

diagnosis: ANCA PR3+ + 90%

  • biopsy: necrotising granulomatous inflammation

treatment: prednisone, azthioprine, MTX

prognosis: often recurrent

22
Q

Eosinophilic granulomatosis with polyangitis

(Churg-Strauss syndrome)

A

pathogenesis: SMALL vessel vasculitis

clinical:

prodrome (2nd-3rd decade): atopy, rhinitis, asthma

eosinophilic phase: serum eosinophilia, organ infiltration (lung/GI/skin)

vasculitis phase (3rd-4th decade): systemic vasculitis medium/small vessels with vascular and extravascular granulomatosis

systems:

  • skin: subcutaneous nodules, LN
  • CVS: pericarditis, arrhythmia, VTE
  • neuro: peripheral neuropathy
  • renal: glomerulonephritis
  • msk: migrating polyarthralgias

diagnosis: eosinophils >5000, pANCA +40%, biopsy

prognosis: high risk of relapse

23
Q

Disorders with panniculitis

A

inflammatory: erythema nodosum, lipodermatosclerosis, SLE, polyarteritis nodosa, erythema induratum

infection

trauma: traumatic, cold, factitial

deposition: calciphylaxis, gout

enzyme destruction: pancreatic panniculitis, alpha-1 antitrypsin def

malignancy: subcutaneous lymphoma

24
Q

Mixed Connective Tissue Disease

(MCTD)

A

definition: overlap syndrome of SLE, scleroderma and polymyositis

clinical:

  • several years post unexplained Raynaud’s phenomenon in 2nd/3rd decade
  • early: joint pain, puffy fingers, low grade myositis
  • later: fatigue, fever, synovitis, inflammatory muscle disease, sclerodactyly, trigeminal neuropathy and scleroderma

diagnosis:

1. Raynaud’s and swollen hands

2. Absence severe renal/CNS disease

3. Severe arthritis/pulmonary HTN

4. anti U1 ribonucleoprotein (RNP) high titres

** abnormal nail capillaroscopy

25
Q

Raynaud’s phenomenon

A

cause: primary or secondary (ScL, SLE or other connective tissue disease)

clinical: colour change with blanching cyanosis and hyperanaemia

diagnosis:

  • symmetric episodic attacks
  • no evidence PVD
  • no gangrene/digital pitting/tissue injury
  • negative nailfold capillary examination
  • negative ANA and normal ESR
26
Q

Anti-GBM disease

A

pathogenesis: auto Ab against type IV collagen

clinical: pulmonary-renal syndrome w/o prodrome

  • renal: rapidly progressive GN (20% cresenteric)
  • pulmonary (70%): Goodpasture’s syndrome

diagnosis:

  • 1/3 pANCA MPO+
  • anti-GBM Ab
  • renal biopsy: IgG, C3 staining in capillary loops glomeruli

treatment: prednisone, cyclophosphamide

27
Q

Sarcoidosis

A

definition: multisystem granulomatous disorder of unknown etiology causing noncaseating granulomas in multiple organs

clinical:

  • LN (40%): bilateral hilar adenopathy, swelling parotid, salivary
  • pulmonary: reticular opacities
  • skin (25%): papular, nodular, plaque lesions, erythema nodosum
  • ocular (25%): uveitis, keratoconjunctivitis sicca
  • musculoskeletal (10%): polyarthritis, myositis
  • other: endocrine, renal, CNS, CVS (arrythmia, HB), GI

symptoms: cough, dyspnoea, chest pain, fatigue, malaise, weight loss

lofgren sx: EN, hilar LN, migratory polyarthritis, fever

diagnosis:

  • AI: ANA +ve 90%, RF, anti-Ro/anti-La, ACE (monitor)
  • serum: increased eosinophils, anaemia/thrombocytopaenia/leukopaenia, elevated ACE (75%), hypergammaglobulinaemia
  • biopsy: noncaseating granuloma lung
28
Q

Polyarteritis Nodosa

A

incidence: RARE in childhood

pathophysiology: idiopathic systemic necrotizing vasculitis affecting small/medium muscular arteries of every system except lungs

  • may be secondary to Hep B/Hep C/hairy cell leukaemia

clinical: mean age 9 years

  • systemic: fever, fatigue, myalgia
  • skin: purpura, livedo reticularis, bullous/vesicular eruptions, tender subcut nodules
  • renal: afferent arteriolar narrowing with ischaemia, HTN
  • neuro: mono/polyneuropathy
  • GI: abdominal pain/ischaemia (small>large bowel, weight loss
  • msk: myaglia (elevated CK)
  • CVS: ischaemia, infarction

infantile form: <2yrs, coronary arteries with aneurysm/CCF

diagnostic cx: biopsy arteries + skin/muscle/HTN/PN/renal sx

treatment: steroids, MTX, cyclophosphamide

prognosis: 1 yr survival 50%, 5 yr survival 13%

29
Q

Henoch Schonlein Purpura

HSP

A

incidence: most common childhood vasculitis

clinical: mean 6-7yrs

  • skin (100%): purpura, petechiae
  • GI: abdo pain (30%), nausea, vomiting, ileal-ileal intussusception (3.5%), ischaemia
  • arthritis (40%): migratory, oligoarticular, LL
  • renal (50%): IgA nephropathy (haematuria, casts, proteinuria) within 6 months with secondary HTN
  • other: headaches, seizures, ICH, keratitis, uveitis

diagnosis: skin changes + 1 other sx

management: NSAIDs, steroids, immunosuppresants if renal

prognosis: 1/3 reoccur within 4 months

30
Q

Kawasaki Disease

A

incidence: boys>girls <5yrs asian

pathophysiology: unknown etiology possibly infective

  • seasonal with clusters
  • familial clustering
  • fever due to cytokines TNF/IL-6 and minimally responsive to anti-pyretics

clinical: fever >5 days with 4 of 5 of the following

1. polymorphous rash (70-90%)

2. change of extremities (50-80%): oedema/erythema palms/soles, periungal desquamation wk 2/3, arthritis

3. cervical LN: 1 at least >1.5cm (25-70%)

4. bilateral non-purulent conjunctivitis (>90%), anterior uveitis

5. mucositis (90%): cracked lips, strawberry tongue

  • other: pneumonitis, URTI, D/V, sterile pyuria

complications:

  • cardiac: coronary artery aneurysm/arteritis (<1yr or >9yr, male, fever>14d), pericardial effusion, valvular regurg
  • CVS: peripheral arterial obstruction
  • other: SNHL, macrophage activation syndrome, behavioural issues

diagnosis:

  • TTE at 2 weeks/8 weeks
  • serum: elevated ESR/CRP/WCC/platelets/transaminases
  • CSF: pleiocytosis

management: IVIG 2g/kg within 10 days, high dose aspirin 30mg/kg

prognosis: mortality 0.1%, coronary aneurysm (1% treated, 30% untreated)

31
Q

Juvenille Dermatomyositis

A

incidence: most common idiopathic inflammatory myopathy of childhood, F>M

clinical: 5-10yrs

symmetrical proximal muscle weakness: diffculty stairs, Gower’s sign, swallowing issues

PLUS 2 of the following cutaneous sx:

  1. heliotrope dermatitis: purple rash on eyelids with periorbital oedema
  2. Gottran’s papules: red papules/plaques to knuckles
    other: nail-fold capillary changes, skin ulcers, calcinosis skin/muscle, non-erosive arthritis, lisodystrophy, anorexia, fever, cardiac disease, ILD

diagnosis:

  • AI: positive polymyositis (Pm) or scleroderma (Scl) antibodies, ANA (80%)
  • serum: elevated CK, anaemia, lymphopaenia
  • EMG: myopathy

treatment: steroids, MTX, IVIg, cyclosporine

complications: OP, calcinosis (delayed tx)

32
Q

ANA sensitivity

A
33
Q

SLE diagnosis

A

DAMP AS RHINO (4 of 11):

Discoid rash

ANA +

Malar rash

Photosensitivity

Arthritis

Serositis (lung/heart)

Renal involvement: >0.5g protein/casts

Haem abnormality: anaemia, thrombocytopaenia, cytopaenia

Immune abnormalities: dsDNA, Sm, LAC, aCL

Neuro abnormalities: seizures, psychosis

Oral/nasal ulcers

34
Q

ANA

A
35
Q

Relapsing panniculitis

(Weber-Christian disease)

A

definition: idiopathic relapsing febrile non suppurative panniculitis in 30-60yo females usually affecting the lower limbs

36
Q

Macrophage Activating Syndrome

A

incidence: 8% SJIA

definition: secondary form HLH

clinical: fever, rash, HSM

diagnosis:

  • ferritin>684 PLUS
  • platelets<181
  • AST>48
  • TG>156
  • Fibrinogen<360

prognosis: 30% mortality